A detailed history of Hsbc Holdings PLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 36,412 shares of NKTX stock, worth $85,568. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,412
Holding current value
$85,568
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.52 - $8.0 $164,582 - $291,296
36,412 New
36,412 $164,000
Q1 2024

May 15, 2024

SELL
$5.59 - $15.71 $34,048 - $95,689
-6,091 Reduced 32.34%
12,746 $137,000
Q4 2023

Feb 12, 2024

BUY
$1.31 - $6.6 $31 - $158
24 Added 0.13%
18,837 $124,000
Q2 2023

Aug 11, 2023

SELL
$2.19 - $5.17 $33,130 - $78,211
-15,128 Reduced 44.57%
18,813 $41,000
Q1 2023

May 15, 2023

BUY
$3.37 - $6.3 $52,915 - $98,922
15,702 Added 86.09%
33,941 $120,000
Q4 2022

Feb 14, 2023

BUY
$5.14 - $14.35 $93,748 - $261,729
18,239 New
18,239 $109,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $114M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.